Related Experiment Video
Updated: Aug 12, 2026
One-step Protocol for Evaluation of the Mode of Radiation-induced Clonogenic Cell Death by Fluorescence Microscopy
Published on: October 23, 2017
Retrospective Analysis of Acute Toxicity Following Breast Cancer Re-Irradiation
Alyssa Jiaxin Wang1, Shely Kagan2, Liying Zhang3
1Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Purpose:
To evaluate the acute skin toxicity and treatment-related factors in patients undergoing breast re-irradiation in a tertiary cancer centre.
Methods:
A retrospective review was conducted of patients who received a repeat course of breast or chest wall radiation for ipsilateral breast cancer recurrence between April 20, 2011, and December 31, 2023. Patient characteristics, treatment parameters, and clinician-graded acute toxicity were recorded. Associations between toxicity and treatment factors were analyzed.
Results:
Seventy patients met inclusion criteria. Acute skin toxicity was lower during retreatment than initial treatment with 22.9% of patients (n = 16) developing moderate/severe reactions during re-irradiation compared with 51.4% (n = 36) during the initial course. Severe toxicity at retreatment was not common, including moist desquamation in 10 patients (14.3%). Toxicity during the initial course did not predict toxicity during re-irradiation (P = .75). Across all fractionation schedules, no significant associations were observed between dose regimen and symptoms such as pruritus, pain, erythema, discoloration, edema, burning, dry desquamation or moist desquamation.
Conclusions:
Breast re-irradiation was well tolerated in the acute setting, with toxicity patterns influenced primarily by radiation dose and delivery. The findings emphasize the need for ongoing prospective work to assess long-term outcomes.
